Abstract: Maternal zinc deficiency seems to be a risk factor for orofacial clefts in offspring. This study was undertaken to investigate the involvement of polymorphic variants of genes for zinc transporters in the susceptibility of clefting. PCR-RFLP analysis was used to analyze single nucleotide polymorphisms of SLC30A1 (rs7526700, rs2278651, rs611386), SLC30A4 (rs2453531, rs8029246), SLC30A5 (rs351444, rs164393, rs6886492), SLC39A1 (rs10127484, rs11264736), and SLC39A3 (rs759071, rs4806874, rs10415622) in mothers of children with non-syndromic cleft lip with or without cleft palate (CL/P) and control mothers. The allele, genotype, and haplotype distribution was found to be similar among case and control mothers. Also, the gene-by-gene interaction analysis conducted using the Multifactor Dimensionality Reduction approach revealed no significant interactive genetic effect on having a child with a cleft. In conclusion, our results demonstrated that the analyzed polymorphic variants of genes for zinc transporters are not implicated in abnormal palatogenesis in the investigated group of women from the Polish population.
Introduction
Zinc (Zn) is an essential dietary micronutrient that plays fundamental integrative roles in human physiology. The functions of Zn can be divided into three categories: structural, catalytic, and regulatory. It is estimated that 3-10% of human genes code for proteins with Zn binding domains [1] . Since Zn cannot passively diffuse across cell membranes its transport is carried out by Zn transporters. Two major unrelated families of mammalian Zn transporters have been identified: solute-linked carriers 30A (SLC30A, also called ZnTs) and SLC39A (ZIPs) [2] . Zinc uptake is mediated by the SLC39A protein family, while members of the SLC30A family transport zinc from the cytoplasm to the lumen of organelles or the extracellular space [3] . There is no storage form of Zn in the body that can be readily mobilized when dietary intake is inadequate. However, it has been shown that Zn transporter expression can be regulated by both transcriptional and post-transcriptional mechanisms in response to Zn availability to ensure an appropriate plasma concentration of this nutrient [3] . Zn transporters have been strongly implicated in embryonic, fetal, and neonatal development [2] [3] [4] [5] . SLC30A1 and SLC30A5 play a key role in regulating delivery of maternal Zn to the developing embryo [2, 5] . Cadmium exposure, which is known to be risk factor for congenital anomalies, down-regulates Slc30a1 expression, indicating that maternal cadmium exposure may alter Zn homeostasis in the conceptus [5] . Mutations in ZnTs and ZIPs reveal their physiological functions [3] . Mutations in SLC30A4 have been associated with a loss or reduction of Zn secretory activity of some glandural epithelial cells, however the regulation of Zn transporter proteins in histiotrophic nutrition in early pregnancy has yet to be elucidated [3, 6, 7] . Mutations in human SLC39A4 cause the rare disease acrodermatitis enteropathica [8] . Interestingly, it was been found that in the mouse, maternal Slc39a4 haploinsufficiency results in increased sensitivity to the effects of Zn deficiency and the risk of abnormal embryonic development [8] . Recently, Kambe et al. [9] demonstrated that the Slc39a1, 2, and 3 genes evolved to decrease sensitivity to the stress of dietary Zn deficiency in the reproducing mouse. The high degree of evolutionary conservation of ZIP1, 2, and 3 suggests the possibility of these genes' involvement in protection against Zn deficiency in human pregnancies [9] .
Cleft lip with or without cleft palate (CL/P) is one of the most common congenital malformations in humans. The aetiology of CL/P is highly complex and associated with both genetic and multiple environmental factors, including micronutrient deficiencies [10] . The correlation between abnormal palatogenesis and Zn dyshomeostasis has been clearly documented in laboratory animals [11] . In humans, poor maternal Zn status may be a risk factor for clefting when the micronutrient deficiency reaches a certain severity [12, 13] . Observations in the rodent model indicate that the Zn transporter genes can be silent when dietary intake of Zn is normal in pregnancy, but they might be involved in buffering the micronutrient deficiency and the success of reproduction can be dramatically compromised [14, 15] . Such findings have prompted the search for cleft-associated variants of Zn transporters. Therefore, the present study was designed to test single nucleotide polymorphisms (SNPs) of the SLC30A and SLC39A genes as risk factors of having a child with CL/P in the Polish population.
Materials and methods
Participants. The study was approved by the local ethics committee. Index patients with non-syndromic cleft lip with or without cleft palate were chosen by clinicians using detailed diagnostic information from medical records in the Department of Paediatrics and Department of Paediatric Surgery at the Institute of Mother and Child in Warsaw. Peripheral blood samples from 149 healthy mothers of children with orofacial clefts were obtained. In addition, 100 healthy mothers of children without congenital anomalies were used as controls (control mothers). All participating omnivorous women, aged 18-45 years, were Caucasians of Polish origin recruited from the same geographic region. Written and oral consent was obtained from all subjects.
Genotyping. DNA was isolated from peripheral blood lymphocytes by salt extraction. All 13 analyzed polymorphic variants of SLC30A1, SLC30A4, SLC30A5, SLC39A1, and SLC39A3 were identified using PCR followed by appropriate restriction enzyme digestion (PCR-RFLP). DNA fragments were separated using electrophoresis on 2% agarose gel and visualized using ethidium bromide staining. Primer sequences and conditions for PCR-RFLP analyses are presented in Table 1 . The selection of SNPs was conducted through the use of the genome browser of the International HapMap Consortium (www.hapmap.org). SNPs were prioritized according to their validation status, functional relevance and importance, and minor allele frequency MAF>0.1 in the Caucasian population.
Statistical analysis. The differences in allele and genotype frequencies between case mothers and controls were determined using standard χ 2 and Fisher exact tests. The odds ratio (OR) and associated 95% confidence intervals (95% CI) for mothers of children with CL/P versus control mothers were also calculated.
Haplotype analysis was performed using Haploview 4.0 (http://www.broadinstitute.org/mpg/haploview). Associations between the investigated polymorphisms and the risk of having a child with an orofacial cleft were tested using the nonparametric and genetic model-free Multifactor Dimensionality Reduction (MDR) approach (MDR version 2.0 beta 5). Statistical significance was evaluated using a 1,000-fold permutation test (MDR permutation testing module 0.4.9 alpha). A p-value of <0.05 was considered statistically significant.
Results
For all analysed polymorphisms of the SLC30A1, SLC30A4, SLC30A5, SLC39A1, and SLC39A3 genes there was no evidence for both allelic and genotyping association with the risk of being a case mother in the Polish population. The genotyping results are presented in Table 2 . No deviation from Hardy-Weinberg equilibrium in either CL/P mothers or control mothers at the 0.05 level was observed. The minor allele frequency for all SNPs was at least 0.19. Haplotype analysis did not detect differences in haplotype distribution between case and control mothers (Table 3) . Moreover, the exhaustive MDR analysis revealed no significant interactive genetic effect on having a child with CL/P for all analysed SNPs (Table 4 ). All possible two-, three-and four-way SNP interactions were tested using 10-fold cross validation in an exhaustive search (considering all possible SNP combinations). All of the "best models" (showing highest testing balanced accuracy and cross validation consistency >5 out of 10) did not reach the statistical significance evaluated using a 1,000-fold permutation test.
Discussion
Genetic studies in humans have shown associations between expression profiles of genes for Zn transporters and chronic diseases (diabetes, asthma) as well as carcinogenesis [16, 17] . Since craniofacial malformations arise from misregulation of normally coordinated tissue patterns during early embryogenesis [10] , another interesting aspect of Zn transporter function is the possibility of these proteins' involvement in early embryonic nutrition. It has been demonstrated that the expression of the Slc30a1 gene is highly active in the yolk sac of the developing mouse embryo, and this expression is partially dependent on maternal Zn intake [18] . Due to the key role of Zn in human physiology, the aim of this study was to verify possible contributions of Zn transporter gene SNPs to orofacial clefting. To our knowledge, the present report is the second association study examining the potential role of genes encoding Zn transporters in the aetiology of non-syndromic structural malformations in affected progeny. In a sample of Dutch triads of patients and their parents, no association was observed between the 1069C>T (rs2272662) variant of SLC39A4 and spina bifida [19] . In our study the investigated SNPs were not found to be associated with the women's risk of having children with CL/P, analyzed either separately or in combination. We analyzed three polymorphisms of the gene for the SLC30A1 protein, which plays an essential function in transporting maternal Zn into the embryo, and two polymorphic variants of the gene for SLC39A1 protein, which has been detected in a wide variety of tissues and cell types [3] . It has been shown that mRNA levels of both SLC30A1 and SLC39A1 may be potential Zn status indicators in the human lymphoblastoid cell line [20] . In women of childbearing age supplemented with Zn, the expression of SLC39A1 in leucocytes has been reported to decrease significantly, whereas there were no changes in the mRNA levels of SLC30A1 [20] . Therefore, SLC39A1 mRNA expression is considered a potential biomarker of Zn status in humans. In contrast to these predictions, the allele and genotype distribution of SLC30A1 and SLC39A1 polymorphic variants was found to be similar among the investigated mothers of CL/P affected children and controls.
In the present study, the allele distribution of SLC30A5 rs351444 showed the highest difference between case and control mothers. Moreover, the risk of having a CL/P affected child for the maternal rs351444 GG genotype compared with the wild type tended to be decreased (OR=0.55; 95%CI: 0.26-1.16; p=0.11). Interestingly, haplotype analysis of SLC30A5 polymorphic variants (rs351444, rs164393, and rs6886492) showed borderline association between the CTA haplotype and increased risk of clefting (p=0.051).
Expression of SLC30A4 appears to be independent of Zn status, which is contrary to SLC30A1, SLC30A5, SLC39A1, and SLC39A3 [21] . It is noteworthy that there was no evidence for association of polymorphic variants of SLC30A4 with CL/P risk. The analysis of epistasis is helpful in determining the true contribution of genetic factors to congenital anomaly susceptibility [22] . However, in our study the exhaustive MDR analysis revealed no significant interactive effect of polymorphic variants of the genes for Zn transporters on abnormal palatogenesis. There are no previously published clinical association studies of the SNPs analyzed in the present report, and so we are unable to compare our results with data from other studies.
However, our negative results do not exclude the potential role of polymorphisms of Zn transporter genes in the aetiology of CL/P. The results might be influenced by the sample size, which may not be large enough to detect a modest effect of the analyzed gene variants. We cannot exclude that SNPs in genes for Zn transporters may influence palatogenesis via the embryonic, rather than the maternal, genotype. In humans, some of genes for Zn transporters may have a restricted expression to only fetal tissues [23] . Therefore, the exclusion of the investigated SNPs and other variants of genes encoding Zn transporters as risk factors of CL/P in the Polish population requires further analyses, which should be performed in larger groups of case and control mothers as well as in CL/P-affected children. The relatively high and fluctuating frequency of orofacial clefts is attributable to the sensitivity of facial development to environmental insult. Recent progress in our understanding of the molecular functions of Zn transporters and their clinical associations has revealed that additional analysis involving polymorphisms of SLC30A8 and SLC39A14 may throw a new light on the aetiology of CL/P. Maternal diabetes and infection with the common cold during early pregnancy are well known risk factors for abnormal palatogenesis [10, 24] . SLC39a14 plays a major role in hypozincemia induced by inflammation, which is among the classical changes observed during acute infections [3] . In rodents, dietary Zn supplementation decreases the frequency of malformations caused by bacterial lipopolysaccharides [25] . The association between some polymorphisms of SLC30A8 and the onset of diabetes mellitus is well documented in humans [3] .
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